Research Catalog
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary
- Title
- Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary / Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
- Publication
- Washington, D.C. : National Academies Press, [2009], ©2009.
Items in the Library & Off-site
Filter by
2 Items
Status | Format | Access | Call Number | Item Location |
---|---|---|---|---|
Text | Request in advance | RA401.A3 B74 2009g | Off-site | |
Not available - Please for assistance. | Text | Use in library | Off-site |
Holdings
Details
- Additional Authors
- Description
- xviii, 132 pages : illustrations; 23 cm
- Summary
- "The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development".
- Subject
- Bibliography (note)
- Include bibliographical references (p. 104-105).
- Additional Formats (note)
- Also available online.
- Contents
- Introduction and overview -- Current model for financing drug development: from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary.
- ISBN
- 0309120888
- 9780309120883
- OCLC
- ocn317114592
- 317114592
- SCSB-5462450
- Owning Institutions
- Columbia University Libraries